Sign in
4

Changes in Ownership

Protara Therapeutics, Inc. Filed Acc 0001209191-20-051631

Chief Financial Officer bought 1,481 shares at $16.91 ($25,038)

From the SEC's structured data for this filing

Trades in this filing

Davis Blaine · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-09-22 Purchase : show line 1 in the form +1,481 $16.91 $25,038 1,481 D
Open-market purchases · 1,481 sh · avg $16.91 · $25,038
Loading xslF345X03/doc4.xml…